Abstract
The 'growth fraction' of tumours can now be assessed on paraffin sections of tissues using the monoclonal antibody MIB1 by a microwave antigen retrieval technique. The MIB1 labelling index was studied using a CAS 200 image analyser in 177 tumours from women with primary operable breast carcinoma in whom long-term follow-up data were known. Statistical analysis showed a strong association between the MIB1 labelling index and histological grade (P < 0.001), tumour size (P = 0.002), tumour type (P < 0.001) and also patient survival (P < 0.001). No association with lymph node stage (P = 0.974) or regional recurrence (P = 0.185), the presence or absence of distant metastases (P = 0.418), patient age (P = 0.309), menopausal status (P = 0.181) or oestrogen receptor status (P = 0.401) was found in this group of patients. In multivariate analysis for survival, when histological grade, lymph node stage and tumour size were included as well as the MIB1 labelling index, each was found to be of independent significance. If histological grade was not included, MIB1 replaced it as the most important variable predicting for survival in this group of patients. The results suggest that the tumour growth fraction, as assessed by the MIB1 labelling index, is an important predictor of survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pinder, S., Wencyk, P., Sibbering, D. et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 71, 146–149 (1995). https://doi.org/10.1038/bjc.1995.30
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.30
This article is cited by
-
Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers
Breast Cancer Research and Treatment (2024)
-
Ki-67 Index and Its Correlation with Clinical and Pathological Variables in Breast Cancer
Indian Journal of Surgical Oncology (2023)
-
Machine learning-based prediction of breast cancer growth rate in vivo
British Journal of Cancer (2019)
-
Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists
Breast Cancer (2018)
-
Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset
Breast Cancer Research and Treatment (2017)